Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rodrigo Lázaro‐Gorines
Observed names:
Lázaro Gorines, Rodrigo,
R. Lázaro-Gorines,
Rodrigo Lázaro-Gorines
Institutions:
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre
Observed institutions:
Universidad Complutense de Madrid,
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre
ORCID:
0000-0002-6885-3486
Observed ORCID:
0000-0002-6885-3486
OpenAlex ID:
A5027042998
Fungal Ribotoxins: A Review of Potential Biotechnological Applications
2017
·
Miriam Olombrada
, Rodrigo Lázaro-Gorines
, et al.
·
Toxins
·
85
PDF
A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts
2019
·
R. Lázaro-Gorines
, J. Ruiz-de-la-Herrán
, et al.
·
Scientific Reports
·
43
PDF
A TIM-3–Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia
2025
·
Aïda Falgàs
, Rodrigo Lázaro-Gorines
, et al.
·
Blood
·
22
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response
2023
·
Laura Rubio-Pérez
, Rodrigo Lázaro-Gorines
, et al.
·
OncoImmunology
·
20
Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity
2022
·
Oana Hangiu
, Marta Compte
, et al.
·
iScience
·
18
PDF
Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins
2019
·
Javier Ruiz-de-la-Herrán
, Jaime Tomé-Amat
, et al.
·
Toxins
·
14
PDF
Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates
2024
·
Rocío Navarro
, Susana Frago
, et al.
·
Toxicology and Applied Pharmacology
·
6
Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity
2024
·
Laura Rubio-Pérez
, Susana Frago
, et al.
·
Antibodies
·
6
PDF
Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS‐CoV‐2
2023
·
Rodrigo Lázaro‐Gorines
, Patricia Pérez
, et al.
·
Advanced Science
·
6
PDF
Der p 1-based immunotoxin as potential tool for the treatment of dust mite respiratory allergy
2020
·
Rodrigo Lázaro-Gorines
, Juan Carlos López-Rodríguez
, et al.
·
Scientific Reports
·
6
PDF
Generation and functional evaluation of bispecific T cell engaging antibodies
2025
·
Antonio Tapia-Galisteo
, Rodrigo Lázaro-Gorines
, et al.
·
Methods in cell biology
·
1
An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin
2025
·
Javier Narbona
, Rodrigo Lázaro-Gorines
, et al.
·
International Journal of Molecular Sciences
PDF
Show more works
View as search
Works count:
13
Citation count:
227
H-index:
6
I10-index:
6
Year
Topic
Type